• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15900046).
  

PubMed=8882729; DOI=10.1093/oxfordjournals.jbchem.a021246
Ayano Satoh, Eiji Takayama, Kiyoko Kojima, Haruko Ogawa, Takao Yamori, Shigeo Sato, Tokuichi Kawaguchi, Takashi Tsuruo, Yoshimoto Katsura, Tatsuo Kina, Isamu Matsumoto;
Expression of carbohydrate-binding protein p33/41 in human tumor cell lines.
J. Biochem. 119:346-353(1996)

PubMed=15767549; DOI=10.1158/1535-7163.MCT-04-0234
Noriyuki Nakatsu, Yoko Yoshida, Kanami Yamazaki, Tomoki Nakamura, Shingo Dan, Yasuhisa Fukui, Takao Yamori;
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
Mol. Cancer Ther. 4:399-412(2005)

PubMed=15900046; DOI=10.1093/jnci/dji133
Tetsuo Mashima, Tomoko Oh-hara, Shigeo Sato, Mikiko Mochizuki, Yoshikazu Sugimoto, Kanami Yamazaki, Jun-ichi Hamada, Mitsuhiro Tada, Tetsuya Moriuchi, Yuichi Ishikawa, Yo Kato ...Show all 14 authors... , Hiroshi Tomoda, Takao Yamori, Takashi Tsuruo; Show fewer authors
p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
J. Natl. Cancer Inst. 97:765-777(2005)

PubMed=22336246; DOI=10.1016/j.bmc.2012.01.017
De-Xin Kong, Takao Yamori;
JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
Bioorg. Med. Chem. 20:1947-1951(2012)